| 5001 | PACS2 levels | GCST90470141 | 0.36 |
| 5002 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17 | ECGA000017 | 0.36 |
| 5003 | MCFD2/VSIR ratio | GCST90315411 | 0.36 |
| 5004 | MPIG6B/SUSD1 ratio | GCST90315487 | 0.36 |
| 5005 | Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302775 | 0.36 |
| 5006 | CST3 levels | UKBB00000163 | 0.36 |
| 5007 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377 | ECGA000377 | 0.36 |
| 5008 | CASP7 levels | GCST90468547 | 0.36 |
| 5009 | TBCB levels | GCST90470813 | 0.36 |
| 5010 | AMY1A or AMY1B or AMY1C levels | GCST90468297 | 0.35 |
| 5011 | EFNB2 levels | GCST90469082 | 0.35 |
| 5012 | X-12749 levels | GCST90243770 | 0.35 |
| 5013 | LACRT levels | GCST90469725 | 0.35 |
| 5014 | PRKAR1A levels | GCST90470326 | 0.35 |
| 5015 | DKK1/VTA1 ratio | GCST90314485 | 0.35 |
| 5016 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320646 | 0.35 |
| 5017 | CNST/DOK2 ratio | GCST90314157 | 0.35 |
| 5018 | AXL/MCAM ratio | GCST90313421 | 0.35 |
| 5019 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381 | ECGA000381 | 0.35 |
| 5020 | Haematocrit percentage | Blood count | UKBB00000292 | 0.35 |
| 5021 | CD79B/CKAP4 ratio | GCST90313898 | 0.35 |
| 5022 | Triacylglycerol_54:5_[M+NH4]1+ levels | GCST90060539 | 0.35 |
| 5023 | APOD levels | GCST90468337 | 0.35 |
| 5024 | PSME2 levels | GCST90470361 | 0.35 |
| 5025 | EHD3 levels | GCST90469089 | 0.35 |
| 5026 | Insomnia complaints | GCST006487 | 0.35 |
| 5027 | Other joint disorders | FING00001064 | 0.35 |
| 5028 | X-24947 levels | GCST90200651 | 0.35 |
| 5029 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107 | ECGU000107 | 0.35 |
| 5030 | B4GALT1 levels | GCST90468412 | 0.35 |
| 5031 | Operation code - hip replacement/revision | Operations | UKBB00000558 | 0.35 |
| 5032 | CCL4 levels | GCST90012052 | 0.35 |
| 5033 | wg rh intensity-contrast rostralanteriorcingulate | GCST90003852 | 0.35 |
| 5034 | FGFBP3 levels | GCST90469232 | 0.35 |
| 5035 | AGER levels | GCST90012054 | 0.35 |
| 5036 | Depression | FING00000398 | 0.35 |
| 5037 | BMP4 levels | GCST90468453 | 0.35 |
| 5038 | Wet age-related macular degeneration | FING00001448 | 0.35 |
| 5039 | aseg lh intensity Pallidum | GCST90003771 | 0.35 |
| 5040 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380 | ECGA000380 | 0.35 |
| 5041 | Platelet count | GCST90018749 | 0.35 |
| 5042 | Free cholesterol levels in HDL | GCST90092824 | 0.35 |
| 5043 | CST1 levels | GCST90468893 | 0.34 |
| 5044 | IDP dMRI ProbtrackX ICVF fmi | GCST90004386 | 0.34 |
| 5045 | VSNL1 levels | GCST90471054 | 0.34 |
| 5046 | Types of transport used (excluding work) - Public transport | Physical activity | UKBB00000878 | 0.34 |
| 5047 | INPP1/TBCC ratio | GCST90315180 | 0.34 |
| 5048 | MAP2K6 levels | GCST90469852 | 0.34 |
| 5049 | HBB levels | GCST90025969 | 0.34 |
| 5050 | CD19 on IgD- CD27- B cell | GCST90001732 | 0.34 |
| 5051 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11 | ECGA000011 | 0.34 |
| 5052 | DTI TBSS MD Uncinate fasciculus R | GCST90384616 | 0.34 |
| 5053 | GRAP2/PTPN6 ratio | GCST90314986 | 0.34 |
| 5054 | IGLL1 levels | GCST90241473 | 0.34 |
| 5055 | aparc-a2009s rh area S-postcentral | GCST90003437 | 0.34 |
| 5056 | REG4/SPINK4 ratio | GCST90315766 | 0.34 |
| 5057 | BA-exvivo lh area BA1 | GCST90003207 | 0.34 |
| 5058 | IGFBP4/OGN ratio | GCST90315134 | 0.34 |
| 5059 | ITGB1/REG1A ratio | GCST90315228 | 0.34 |
| 5060 | Ever sought or received professional help for mental distress | Mental distress | UKBB00000222 | 0.34 |
| 5061 | DOK2/PPP1R12A ratio | GCST90314536 | 0.34 |
| 5062 | Congenital malformations of the circulatory system | FING00000340 | 0.34 |
| 5063 | IDP dMRI ProbtrackX L1 slf r | GCST90004268 | 0.34 |
| 5064 | CD84/SEMA4D ratio | GCST90313917 | 0.34 |
| 5065 | IDP dMRI ProbtrackX ICVF cst l | GCST90004383 | 0.34 |
| 5066 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104 | ECGU000104 | 0.34 |
| 5067 | Redundant prepuce, phimosis and paraphimosis | FING00001246 | 0.34 |
| 5068 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 0.34 |
| 5069 | DTI TBSS MD Superior longitudinal fasciculus R | GCST90384612 | 0.34 |
| 5070 | SRC/STAT5B ratio | GCST90315882 | 0.34 |
| 5071 | IDP dMRI TBSS ICVF Medial lemniscus L | GCST90004336 | 0.34 |
| 5072 | Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney disease | GCST90265971 | 0.34 |
| 5073 | Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302763 | 0.33 |
| 5074 | Frequency of depressed mood in last 2 weeks | Mental health | UKBB00000259 | 0.33 |
| 5075 | EGLN1/PSIP1 ratio | GCST90314620 | 0.33 |
| 5076 | ACAN levels | GCST90468196 | 0.33 |
| 5077 | Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302777 | 0.33 |
| 5078 | Bell's palsy | FING00000144 | 0.33 |
| 5079 | EDAR/SNAP23 ratio | GCST90314587 | 0.33 |
| 5080 | Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | GCST90475673 | 0.33 |
| 5081 | Infections of the skin and subcutaneous tissue | FING00000670 | 0.33 |
| 5082 | Impacted cerumen (PheCode 380.4) | GCST90475901 | 0.33 |
| 5083 | EBAG9/TBCC ratio | GCST90314568 | 0.33 |
| 5084 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 0.33 |
| 5085 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 0.33 |
| 5086 | Triacylglycerol_51:2_[M+NH4]1+ levels | GCST90060497 | 0.33 |
| 5087 | eGFR in diabetes mellitus (loose) kidney healthy controls (full adjustment) | GCST90624793 | 0.33 |
| 5088 | Estimated glomerular filtration rate, cystain C | Other measurement | UKBB00000210 | 0.33 |
| 5089 | wg lh intensity-contrast isthmuscingulate | GCST90003801 | 0.33 |
| 5090 | Nontoxic multinodular goiter | endocrine/metabolic | UKBB00000528 | 0.33 |
| 5091 | RSPO1 levels | GCST90470503 | 0.33 |
| 5092 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464) | GCST90269561 | 0.33 |
| 5093 | BACH1/CD2AP ratio | GCST90313435 | 0.33 |
| 5094 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024813 | 0.33 |
| 5095 | RBP7 levels | GCST90470440 | 0.33 |
| 5096 | Atrial flutter (PheCode 427.22) | GCST90475973 | 0.33 |
| 5097 | MATN3 levels | GCST90469865 | 0.33 |
| 5098 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 0.33 |
| 5099 | Thyroiditis, unspecified | FING00001359 | 0.33 |
| 5100 | Treatment/medication code - lisinopril | Medications | UKBB00000850 | 0.33 |
| 5101 | Myocardial fractal dimension (slice 5) | GCST90000291 | 0.33 |
| 5102 | IDP dMRI TBSS ICVF Posterior corona radiata L | GCST90004354 | 0.33 |
| 5103 | AHSP levels | GCST90468264 | 0.33 |
| 5104 | IDP dMRI TBSS ISOVF Posterior thalamic radiation R | GCST90004505 | 0.33 |
| 5105 | ELAC1 levels | GCST90469101 | 0.33 |
| 5106 | Coxarthrosis [arthrosis of hip] | Arthrosis | UKBB00000154 | 0.33 |
| 5107 | Porridge liking | GCST90094815 | 0.33 |
| 5108 | Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555) | GCST90476065 | 0.33 |
| 5109 | ADGRF5 levels | GCST90468239 | 0.33 |
| 5110 | Anal and rectal conditions | digestive | UKBB00000029 | 0.33 |
| 5111 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | GCST90475282 | 0.33 |
| 5112 | HDL cholesterol | GCST90018736 | 0.33 |
| 5113 | Hemoglobin | GCST90002384 | 0.33 |
| 5114 | CRYGD levels | GCST90468876 | 0.33 |
| 5115 | USO1 levels | GCST90471018 | 0.33 |
| 5116 | Volume of right accessory basal nucleus | GCST90475009 | 0.33 |
| 5117 | Open wound of foot except toe(s) alone (PheCode 871.3) | GCST90476286 | 0.33 |
| 5118 | wg lh intensity-contrast superiorparietal | GCST90003820 | 0.32 |
| 5119 | Urine N-acetyl-cadaverine levels in chronic kidney disease | GCST90265541 | 0.32 |
| 5120 | Age spots | GCST006096 | 0.32 |
| 5121 | Placental weight (fetal genotype, adjusted for sex) | GCST90275197 | 0.32 |
| 5122 | ALCAM/CDH5 ratio | GCST90313234 | 0.32 |
| 5123 | FABP1/SULT2A1 ratio | GCST90314755 | 0.32 |
| 5124 | LAT/MANF ratio | GCST90315284 | 0.32 |
| 5125 | X-21829 levels | GCST90200585 | 0.32 |
| 5126 | Heart valve disorders (PheCode 395) | GCST90475913 | 0.32 |
| 5127 | Omega-3 fatty acid levels | GCST90502064 | 0.32 |
| 5128 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382 | ECGA000382 | 0.32 |
| 5129 | Arachidoylcarnitine (C20) levels | GCST90200135 | 0.32 |
| 5130 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T61 | ECGU000061 | 0.32 |
| 5131 | Other peripheral nerve disorders (PheCode 351) | GCST90475842 | 0.32 |
| 5132 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90025434 | 0.32 |
| 5133 | DNAJB2 levels | GCST90469013 | 0.32 |
| 5134 | IDP dMRI ProbtrackX L3 cst l | GCST90004308 | 0.32 |
| 5135 | aparc-DKTatlas rh volume superiorparietal | GCST90002920 | 0.32 |
| 5136 | SPARCL1 levels | GCST90242870 | 0.32 |
| 5137 | Birth weight | GCST007557 | 0.32 |
| 5138 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48) | GCST90320611 | 0.32 |
| 5139 | Calcium levels (UKB data field 30680) | GCST90468065 | 0.32 |
| 5140 | aparc-a2009s lh volume G-front-inf-Opercular | GCST90002936 | 0.32 |
| 5141 | Cardiovascular delta age (difference between ECG-predicted and chronological age) | GCST90239749 | 0.32 |
| 5142 | aparc-pial rh area TotalSurface | GCST90003174 | 0.32 |
| 5143 | SMAD5 levels | GCST90470678 | 0.32 |
| 5144 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461 | ECGA000461 | 0.32 |
| 5145 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 0.32 |
| 5146 | X-18601 levels | GCST90243501 | 0.32 |
| 5147 | CCL15/CCL23 ratio | GCST90313681 | 0.32 |
| 5148 | Valine levels (UKB data field 23467) | GCST90269564 | 0.32 |
| 5149 | creatinine (minimum, inv-norm transformed) | GCST90475232 | 0.32 |
| 5150 | Non-cancer illness code, self-reported - migraine | Medical conditions | UKBB00000520 | 0.32 |
| 5151 | Risk taking | Mental health | UKBB00000759 | 0.32 |
| 5152 | Urine methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265509 | 0.32 |
| 5153 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384 | ECGA000384 | 0.32 |
| 5154 | CEP43 levels | GCST90468715 | 0.32 |
| 5155 | Other noninflammatory disorders of uterus, except cervix | FING00001079 | 0.32 |
| 5156 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62 | ECGU000062 | 0.31 |
| 5157 | IDP dMRI TBSS ICVF Posterior thalamic radiation L | GCST90004356 | 0.31 |
| 5158 | CCL26 levels | GCST90468578 | 0.31 |
| 5159 | EIF2AK2 levels | GCST90469091 | 0.31 |
| 5160 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T64 | ECGU000064 | 0.31 |
| 5161 | Coffee max liking | GCST90094739 | 0.31 |
| 5162 | C3 levels | GCST90468498 | 0.31 |
| 5163 | T1 FreeSurfer DK lh superiortemporal thickness | GCST90385651 | 0.31 |
| 5164 | CIAPIN1/SNAP29 ratio | GCST90314067 | 0.31 |
| 5165 | ITGAM/ITGAV ratio | GCST90315209 | 0.31 |
| 5166 | DKK1/PPCDC ratio | GCST90314477 | 0.31 |
| 5167 | F-bitter food liking (derived food-liking factor) | GCST90094706 | 0.31 |
| 5168 | ALB levels | UKBB00000019 | 0.31 |
| 5169 | EFHD1 levels | GCST90469079 | 0.31 |
| 5170 | hemoglobin (mean, inv-norm transformed) | GCST90475374 | 0.31 |
| 5171 | Childhood maltreatment | GCST90551832 | 0.31 |
| 5172 | Nephrotic syndrome | GCST90018664 | 0.31 |
| 5173 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88 | ECGA000088 | 0.31 |
| 5174 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379 | ECGA000379 | 0.31 |
| 5175 | aparc-Desikan lh area supramarginal | GCST90003103 | 0.31 |
| 5176 | BAG6 levels | GCST90468418 | 0.31 |
| 5177 | Spleen iron concentration | GCST90101831 | 0.31 |
| 5178 | BCAN levels | GCST90468426 | 0.31 |
| 5179 | GPI levels | GCST90469391 | 0.30 |
| 5180 | Pain type(s) experienced in last month - Hip pain | Pain | UKBB00000628 | 0.30 |
| 5181 | Blood urea nitrogen levels | GCST90278623 | 0.30 |
| 5182 | CLEC4D/TGFA ratio | GCST90314117 | 0.30 |
| 5183 | GALNT10/TNFSF12 ratio | GCST90314916 | 0.30 |
| 5184 | Diastolic blood pressure | GCST90278625 | 0.30 |
| 5185 | TSHB levels | GCST90470974 | 0.30 |
| 5186 | CELA3A/KIRREL2 ratio | GCST90314013 | 0.30 |
| 5187 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244 | ECGU000244 | 0.30 |
| 5188 | Lysophosphatidylcholine (22:6) [sn2] levels | GCST90024185 | 0.30 |
| 5189 | GCC1 levels | GCST90469315 | 0.30 |
| 5190 | COMP levels | GCST90468827 | 0.30 |
| 5191 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498 | ECGU000498 | 0.30 |
| 5192 | Cardiac defibrillator in situ (PheCode 426.92) | GCST90475961 | 0.30 |
| 5193 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T118 | ECGA000118 | 0.30 |
| 5194 | ALCAM/ENPP2 ratio | GCST90313236 | 0.30 |
| 5195 | CA4 levels | GCST90468513 | 0.30 |
| 5196 | Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) | GCST90475663 | 0.30 |
| 5197 | DCN levels | GCST90468956 | 0.30 |
| 5198 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 0.30 |
| 5199 | SPINT1 levels | GCST90470727 | 0.30 |
| 5200 | DKK4/REG1B ratio | GCST90314490 | 0.30 |
| 5201 | LEPR levels | GCST90469756 | 0.30 |
| 5202 | PTPRK levels | GCST90470383 | 0.30 |
| 5203 | IL13RA1 levels | GCST90469552 | 0.30 |
| 5204 | Facial skin colour (CIELAB index b* value) | GCST90020056 | 0.30 |
| 5205 | Parental longevity (combined parental attained age, Martingale residuals) | GCST006697 | 0.30 |
| 5206 | CD46/TNFRSF14 ratio | GCST90313838 | 0.30 |
| 5207 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159 | ECGU000159 | 0.30 |
| 5208 | Fruit liking | GCST90094766 | 0.29 |
| 5209 | Pregnancy hypertension | FING00001204 | 0.29 |
| 5210 | PMVK/PRDX5 ratio | GCST90315694 | 0.29 |
| 5211 | ESYT2 levels | GCST90469156 | 0.29 |
| 5212 | Phospholipids to total lipids in small HDL percentage (UKB data field 23644) | GCST90269741 | 0.29 |
| 5213 | APOM/MCAM ratio | GCST90313315 | 0.29 |
| 5214 | TBCC levels | GCST90470814 | 0.29 |
| 5215 | AMY2B levels | GCST90468299 | 0.29 |
| 5216 | Omega-3 fatty acids to total fatty acids percentage | GCST90502467 | 0.29 |
| 5217 | FGD3 levels | GCST90469217 | 0.29 |
| 5218 | DECR1/FXN ratio | GCST90314446 | 0.29 |
| 5219 | Diabetic retinopathy (PheCode 250.7) | GCST90475689 | 0.29 |
| 5220 | SNX5 levels | GCST90470702 | 0.29 |
| 5221 | severe traumatic brain injury, does not include concussion | FING00001300 | 0.29 |
| 5222 | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | GCST90132992 | 0.29 |
| 5223 | CST6/GAL ratio | GCST90314302 | 0.29 |
| 5224 | wg rh intensity-contrast superiortemporal | GCST90003856 | 0.29 |
| 5225 | Osteoarthritis; localized | musculoskeletal | UKBB00000595 | 0.29 |
| 5226 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68 | ECGU000068 | 0.29 |
| 5227 | Nonspecific chest pain | circulatory system | UKBB00000527 | 0.29 |
| 5228 | Oily fish consumption | GCST90132993 | 0.29 |
| 5229 | Age at onset of walking | GCST90651078 | 0.29 |
| 5230 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383 | ECGA000383 | 0.29 |
| 5231 | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302676 | 0.29 |
| 5232 | EPHA2 levels | GCST90469130 | 0.29 |
| 5233 | BST1 levels | GCST90468474 | 0.29 |
| 5234 | Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302649 | 0.29 |
| 5235 | Histidine levels | GCST90497481 | 0.29 |
| 5236 | CCL22 levels | GCST90468574 | 0.29 |
| 5237 | Thyroxine levels | GCST90200293 | 0.29 |
| 5238 | Self-reported risk-taking behaviour | GCST006810 | 0.29 |
| 5239 | Other strabismus | FING00001114 | 0.29 |
| 5240 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T70 | ECGU000070 | 0.29 |
| 5241 | Total Cholesteryl ester levels | GCST90025188 | 0.28 |
| 5242 | SCPEP1 levels | GCST90470553 | 0.28 |
| 5243 | Degree of unsaturation | GCST90502752 | 0.28 |
| 5244 | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | GCST90302766 | 0.28 |
| 5245 | THTPA levels | GCST90470860 | 0.28 |
| 5246 | ThalamNuclei rh volume CeM | GCST90002751 | 0.28 |
| 5247 | Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivity | GCST90302720 | 0.28 |
| 5248 | aparc-Desikan rh volume superiorparietal | GCST90002829 | 0.28 |
| 5249 | Deoxycholic acid glucuronide metabolite level | GCST90616229 | 0.28 |
| 5250 | CD5/CD6 ratio | GCST90313860 | 0.28 |
| 5251 | EFNA1/PIK3IP1 ratio | GCST90314598 | 0.28 |
| 5252 | F-whole food liking (derived food-liking factor) | GCST90094868 | 0.28 |
| 5253 | Idiopathic gout | FING00000658 | 0.28 |
| 5254 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T476 | ECGA000476 | 0.28 |
| 5255 | ANKMY2 levels | GCST90468309 | 0.28 |
| 5256 | IDP dMRI TBSS L2 Posterior limb of internal capsule L | GCST90004142 | 0.28 |
| 5257 | Creatinine levels (UKB data field 30700) | GCST90468067 | 0.28 |
| 5258 | PPIE levels | GCST90242217 | 0.28 |
| 5259 | Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions) | FING00000694 | 0.28 |
| 5260 | Gastrointestinal issues (confirmatory factor analysis Factor 31) | GCST90309365 | 0.28 |
| 5261 | PALM levels | GCST90470154 | 0.28 |
| 5262 | Hearing difficulty problems background noise (UKB data field 2257) | GCST90042885 | 0.28 |
| 5263 | Mackerel liking | GCST90094796 | 0.28 |
| 5264 | HEPH levels | GCST90469446 | 0.28 |
| 5265 | MMP7 levels | GCST90469921 | 0.28 |
| 5266 | CD40LG/MPIG6B ratio | GCST90313825 | 0.28 |
| 5267 | ThalamNuclei rh volume CM | GCST90002742 | 0.28 |
| 5268 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502069 | 0.28 |
| 5269 | PPP1R2 levels | GCST90470304 | 0.28 |
| 5270 | rfMRI amplitudes (ICA100 node 35) | GCST90004623 | 0.28 |
| 5271 | NFKB1 levels | GCST90470037 | 0.27 |
| 5272 | Insomnia (PheCode 327.4) | GCST90475826 | 0.27 |
| 5273 | LRP11 levels | GCST90469796 | 0.27 |
| 5274 | CTF1 levels | GCST90468901 | 0.27 |
| 5275 | SCARF2/TNFRSF21 ratio | GCST90315813 | 0.27 |
| 5276 | Plasma methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265508 | 0.27 |
| 5277 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502077 | 0.27 |
| 5278 | Haemoglobin concentration (UKB data field 30020) | GCST90468074 | 0.27 |
| 5279 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T58 | ECGU000058 | 0.27 |
| 5280 | ARHGEF12 levels | GCST90468358 | 0.27 |
| 5281 | Alanine aminotransferase levels | GCST90025979 | 0.27 |
| 5282 | IDP dMRI ProbtrackX L1 ilf l | GCST90004260 | 0.27 |
| 5283 | TNIP1 levels | GCST90470925 | 0.27 |
| 5284 | Hypothyroidism | GCST90018642 | 0.27 |
| 5285 | APP/PPP1R12A ratio | GCST90313330 | 0.27 |
| 5286 | ADA levels | GCST90468231 | 0.27 |
| 5287 | Glucose (fasting status unknown, maximum, inv-norm transformed) | GCST90475329 | 0.27 |
| 5288 | BA-exvivo rh area BA4a | GCST90003225 | 0.27 |
| 5289 | aparc-a2009s rh volume S-postcentral | GCST90003065 | 0.27 |
| 5290 | Free cholesterol in medium HDL (UKB data field 23570) | GCST90269667 | 0.27 |
| 5291 | PDGFB/UXS1 ratio | GCST90315634 | 0.27 |
| 5292 | Spondylosis and allied disorders (PheCode 721) | GCST90476235 | 0.27 |
| 5293 | BAIAP2 levels | GCST90468419 | 0.27 |
| 5294 | Cholesterol to total lipids in very large HDL percentage (UKB data field 23630) | GCST90269727 | 0.27 |
| 5295 | Arm fat percentage right (UKB data field 23119) | GCST90468158 | 0.27 |
| 5296 | Plasma argininate* levels in chronic kidney disease | GCST90264826 | 0.27 |
| 5297 | F-cooking flavour liking (derived food-liking factor) | GCST90094742 | 0.27 |
| 5298 | wg lh intensity-contrast inferiortemporal | GCST90003800 | 0.27 |
| 5299 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14 | ECGA000014 | 0.27 |
| 5300 | EDAR/ITGB1BP2 ratio | GCST90314580 | 0.27 |
| 5301 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 0.27 |
| 5302 | MMP8/PGLYRP1 ratio | GCST90315465 | 0.27 |
| 5303 | CD300E/CXCL10 ratio | GCST90313796 | 0.27 |
| 5304 | Neutrophil count | GCST90002352 | 0.27 |
| 5305 | ABHD14B/APRT ratio | GCST90313137 | 0.26 |
| 5306 | BA-exvivo rh volume BA2 | GCST90002850 | 0.26 |
| 5307 | Treatment/medication code - quinine | Medications | UKBB00000855 | 0.26 |
| 5308 | AKR1B1 levels | GCST90468273 | 0.26 |
| 5309 | Uterine fibroids | GCST90468154 | 0.26 |
| 5310 | HDL cholesterol levels (UKB data field 23406) | GCST90269503 | 0.26 |
| 5311 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457 | ECGU000457 | 0.26 |
| 5312 | Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney disease | GCST90264207 | 0.26 |
| 5313 | Morbid obesity (PheCode 278.11) | GCST90475765 | 0.26 |
| 5314 | Triacylglycerol_50:5_[M+NH4]1+ levels | GCST90060463 | 0.26 |
| 5315 | TRAF2/WWP2 ratio | GCST90315943 | 0.26 |
| 5316 | Medication use (agents acting on the renin-angiotensin system) | GCST90018768 | 0.26 |
| 5317 | DTI TBSS L1 Fornix | GCST90384433 | 0.26 |
| 5318 | CETN2/PRTFDC1 ratio | GCST90314030 | 0.26 |
| 5319 | Migraine | GCST90468142 | 0.26 |
| 5320 | Body mass index | GCST004904 | 0.26 |
| 5321 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97 | ECGU000097 | 0.26 |
| 5322 | DTI TBSS MD Cingulum hippocampus R | GCST90384608 | 0.26 |
| 5323 | BA-exvivo rh area BA3b | GCST90003224 | 0.26 |
| 5324 | LRIG1 levels | GCST90469794 | 0.26 |
| 5325 | HippSubfield rh volume Whole-hippocampus | GCST90002711 | 0.26 |
| 5326 | IL22 levels | GCST90088066 | 0.26 |
| 5327 | Biological Grandparent (paternal): Diabetes / Sugar | GCST90475549 | 0.26 |
| 5328 | Degree of unsaturation | GCST90502233 | 0.26 |
| 5329 | DTI TBSS L3 Superior longitudinal fasciculus L | GCST90384565 | 0.26 |
| 5330 | Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000428 | 0.26 |
| 5331 | CDCP1/MSR1 ratio | GCST90313938 | 0.26 |
| 5332 | DAB2/LYN ratio | GCST90314365 | 0.26 |
| 5333 | TIMP4 levels | GCST90470872 | 0.26 |
| 5334 | IDP dMRI TBSS FA Anterior limb of internal capsule L | GCST90003894 | 0.26 |
| 5335 | T1 FreeSurfer DK rh cuneus area | GCST90385693 | 0.26 |
| 5336 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133 | ECGU000133 | 0.26 |
| 5337 | Body mass index | GCST90103751 | 0.26 |
| 5338 | Urinary tryptophan to urinary creatinine ratio | GCST90451748 | 0.26 |
| 5339 | Alcohol frequency weekly (weighted GWA) | GCST90267267 | 0.26 |
| 5340 | DTI TBSS MD Fornix | GCST90384577 | 0.26 |
| 5341 | QC SWI-to-T1 linear alignment discrepancy | GCST90006352 | 0.26 |
| 5342 | PLAU levels | GCST90470252 | 0.26 |
| 5343 | SDCCAG8 levels | GCST90470560 | 0.26 |
| 5344 | CXCL5/SERPINE1 ratio | GCST90314354 | 0.26 |
| 5345 | Estimated glomerular filtration rate (creatinine, cystatin c) | GCST90428446 | 0.26 |
| 5346 | Blood cell traits latent factor 8 (white cell) | GCST90559250 | 0.26 |
| 5347 | Sleep disorders | Episodic and paroxysmal disorders | UKBB00000775 | 0.26 |
| 5348 | ING1 levels | GCST90469613 | 0.26 |
| 5349 | MYBPC1 levels | GCST90469969 | 0.25 |
| 5350 | PDGFRB levels | GCST90470192 | 0.25 |
| 5351 | Left bundle-branch block | FING00000716 | 0.25 |
| 5352 | BLMH/PEAR1 ratio | GCST90313519 | 0.25 |
| 5353 | Urate | Blood biochemistry | UKBB00000884 | 0.25 |
| 5354 | IGFBP2 levels | GCST90469528 | 0.25 |
| 5355 | rfMRI connectivity (ICA100 edge 961) | GCST90005814 | 0.25 |
| 5356 | Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers) | FING00000865 | 0.25 |
| 5357 | Fruit intake (standard GWA) | GCST90267282 | 0.25 |
| 5358 | Principal component-derived dietary pattern 28 | GCST90133033 | 0.25 |
| 5359 | Enterocolitis due to Clostridium difficile | FING00000507 | 0.25 |
| 5360 | Triacylglycerol_54:4_[M+NH4]1+ levels | GCST90060540 | 0.25 |
| 5361 | aparc-DKTatlas lh area parstriangularis | GCST90003252 | 0.25 |
| 5362 | ENO2/MANF ratio | GCST90314662 | 0.25 |
| 5363 | DTI TBSS MO Middle cerebellar peduncle | GCST90384620 | 0.25 |
| 5364 | wg rh intensity-contrast lingual | GCST90003839 | 0.25 |
| 5365 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430 | ECGU000430 | 0.25 |
| 5366 | TXNDC5 levels | GCST90470991 | 0.25 |
| 5367 | FKBP1B levels | GCST90469242 | 0.25 |
| 5368 | FSTL3/LTBR ratio | GCST90314883 | 0.25 |
| 5369 | Acquired toe deformities (PheCode 735.2) | GCST90476249 | 0.25 |
| 5370 | aparc-a2009s lh area G-precentral | GCST90003325 | 0.25 |
| 5371 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161 | ECGU000161 | 0.25 |
| 5372 | SEC31A levels | GCST90470563 | 0.25 |
| 5373 | MENT levels | GCST90469886 | 0.25 |
| 5374 | Disorders of other endocrine glands | FING00000450 | 0.25 |
| 5375 | CLEC1B/DAB2 ratio | GCST90314086 | 0.25 |
| 5376 | Lysoalkylphosphatidylcholine (O-24:2) levels | GCST90025438 | 0.25 |
| 5377 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490 | ECGA000490 | 0.25 |
| 5378 | CD69/CHMP1A ratio | GCST90313868 | 0.25 |
| 5379 | PRDX3 levels | GCST90470317 | 0.25 |
| 5380 | Do you currently smoke cigarettes? | GCST90476388 | 0.25 |
| 5381 | CD276 levels | GCST90468614 | 0.25 |
| 5382 | CERT/MAX ratio | GCST90314028 | 0.25 |
| 5383 | Myocardial fractal dimension (slice 2) | GCST90000288 | 0.25 |
| 5384 | Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31) | GCST90476116 | 0.25 |
| 5385 | CCL13/CCL8 ratio | GCST90313676 | 0.25 |
| 5386 | IDP dMRI TBSS ICVF Tapetum R | GCST90004373 | 0.25 |
| 5387 | Multi-trait sum score | GCST90270119 | 0.25 |
| 5388 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59 | ECGA000059 | 0.24 |
| 5389 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60 | ECGA000060 | 0.24 |
| 5390 | PARK7 levels | GCST90470159 | 0.24 |
| 5391 | NPPC levels | GCST90470075 | 0.24 |
| 5392 | Spondylosis without myelopathy (PheCode 721.1) | GCST90476236 | 0.24 |
| 5393 | Osteopathies and chondropathies | FING00000913 | 0.24 |
| 5394 | ENPP7 levels | GCST90469118 | 0.24 |
| 5395 | IDP dMRI ProbtrackX OD fma | GCST90004460 | 0.24 |
| 5396 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 0.24 |
| 5397 | SCARF1/SUSD1 ratio | GCST90315811 | 0.24 |
| 5398 | Intended management of patient (recoded) - No overnight hospital stay | Summary Administration | UKBB00000366 | 0.24 |
| 5399 | Biliverdin levels in chronic kidney disease | GCST90257495 | 0.24 |
| 5400 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143 | ECGU000143 | 0.24 |
| 5401 | Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARB | UKBB00000662 | 0.24 |
| 5402 | Calculus of ureter (PheCode 594.3) | GCST90476147 | 0.24 |
| 5403 | RUNX3 levels | GCST90242706 | 0.24 |
| 5404 | Anxiety, nerves or generalized anxiety disorder | Mental distress | UKBB00000039 | 0.24 |
| 5405 | Hereditary deficiency of other clotting factors | FING00000612 | 0.24 |
| 5406 | Telomere length (principal component 2) | GCST90435145 | 0.24 |
| 5407 | CDHR2/MME ratio | GCST90313963 | 0.24 |
| 5408 | Left ventricular outflow tract obstruction (LVOTO), broad definition | FING00000717 | 0.24 |
| 5409 | aparc-DKTatlas lh volume superiorparietal | GCST90002889 | 0.24 |
| 5410 | CTRC/KIRREL2 ratio | GCST90314309 | 0.24 |
| 5411 | Diverticulitis | GCST90468125 | 0.24 |
| 5412 | ANXA4/LACTB2 ratio | GCST90313293 | 0.24 |
| 5413 | PSME2/RBKS ratio | GCST90315737 | 0.24 |
| 5414 | JAM2/TNFRSF21 ratio | GCST90315242 | 0.24 |
| 5415 | Arm fat percentage left (UKB data field 23123) | GCST90468157 | 0.24 |
| 5416 | Other serious medical condition/disability diagnosed by doctor | Medical conditions | UKBB00000619 | 0.24 |
| 5417 | GFRA1/SPON2 ratio | GCST90314923 | 0.24 |
| 5418 | wg lh intensity-contrast insula | GCST90003826 | 0.24 |
| 5419 | Hemoglobin concentration | GCST004615 | 0.24 |
| 5420 | TMSB10/TRIAP1 ratio | GCST90315924 | 0.24 |
| 5421 | CNP levels | GCST90468798 | 0.24 |
| 5422 | Gastritis and duodenitis | digestive | UKBB00000277 | 0.23 |
| 5423 | Estimated glomerular filtration rate (cystatin c) | GCST90428448 | 0.23 |
| 5424 | Left ventricular outflow tract obstruction, narrow definition | FING00000718 | 0.23 |
| 5425 | X-16087 levels | GCST90200537 | 0.23 |
| 5426 | Other/unspecified dorsalgia | FING00001124 | 0.23 |
| 5427 | EDAR/F2R ratio | GCST90314577 | 0.23 |
| 5428 | Triacylglycerol_52:5_[M+NH4]1+ levels | GCST90060506 | 0.23 |
| 5429 | Medication use (glucocorticoids) | GCST90018780 | 0.23 |
| 5430 | FLT1/TGFB1 ratio | GCST90314857 | 0.23 |
| 5431 | MIF levels | GCST90469906 | 0.23 |
| 5432 | Creatinine | Blood biochemistry | UKBB00000156 | 0.23 |
| 5433 | PRR4 levels | GCST90470338 | 0.23 |
| 5434 | Total cholesterol levels | GCST90239675 | 0.23 |
| 5435 | TIMP3/ZBTB16 ratio | GCST90315921 | 0.23 |
| 5436 | Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivity | GCST90302672 | 0.23 |
| 5437 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434 | ECGU000434 | 0.23 |
| 5438 | Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448) | GCST90132967 | 0.23 |
| 5439 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440 | ECGU000440 | 0.23 |
| 5440 | Tobacco use | FING00001365 | 0.23 |
| 5441 | IDP T1 FAST ROIs L postcent gyrus | GCST90002483 | 0.23 |
| 5442 | Total testosterone levels | GCST90503313 | 0.23 |
| 5443 | Soya milk liking | GCST90094845 | 0.23 |
| 5444 | Raynauds phenomenon disease | GCST90271713 | 0.23 |
| 5445 | Docosahexaenoic acid to total fatty acids percentage | GCST90502284 | 0.23 |
| 5446 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 0.23 |
| 5447 | X-21441 levels | GCST90200581 | 0.23 |
| 5448 | SSNA1 levels | GCST90470750 | 0.23 |
| 5449 | FKBP5 levels | GCST90469244 | 0.23 |
| 5450 | Treatment/medication code - paracetamol | Medications | UKBB00000853 | 0.23 |
| 5451 | ERBIN/SIRT2 ratio | GCST90314696 | 0.23 |
| 5452 | High-grade serous epithelial ovarian cancer | GCST90244168 | 0.23 |
| 5453 | Beer or cider consumption (glasses per month) (UKB data field 1578, 4420) | GCST90132988 | 0.23 |
| 5454 | IDP dMRI TBSS OD Posterior limb of internal capsule R | GCST90004420 | 0.23 |
| 5455 | Varicose veins | GCST90086144 | 0.23 |
| 5456 | Cellulitis and abscess of leg, except foot (PheCode 681.5) | GCST90476166 | 0.23 |
| 5457 | Other mental disorder | mental disorders | UKBB00000614 | 0.22 |
| 5458 | Chronic obstructive pulmonary disease in ever smokers | GCST90016588 | 0.22 |
| 5459 | NOTCH1 levels | GCST90470065 | 0.22 |
| 5460 | Fracture of femur | FING00000552 | 0.22 |
| 5461 | Volume of left medial nucleus | GCST90474892 | 0.22 |
| 5462 | IDP dMRI ProbtrackX ISOVF unc r | GCST90004551 | 0.22 |
| 5463 | Glycine levels | GCST007638 | 0.22 |
| 5464 | APRT levels | GCST90468345 | 0.22 |
| 5465 | TNFRSF10B levels | GCST90012021 | 0.22 |
| 5466 | Number of non-cancer illnesses (weighted GWA) | GCST90267291 | 0.22 |
| 5467 | HGF/MMP9 ratio | GCST90315056 | 0.22 |
| 5468 | Trihexosylcermide (d18:1/18:0) levels | GCST90024738 | 0.22 |
| 5469 | Principal component-derived dietary pattern 1 | GCST90133006 | 0.22 |
| 5470 | KIR2DL3 levels | GCST90469685 | 0.22 |
| 5471 | Cereal intake | Diet | UKBB00000121 | 0.22 |
| 5472 | Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.) | GCST90027638 | 0.22 |
| 5473 | Mother's age | Family history | UKBB00000484 | 0.22 |
| 5474 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T79 | ECGA000079 | 0.22 |
| 5475 | DCTN6/TDRKH ratio | GCST90314436 | 0.22 |
| 5476 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320864 | 0.22 |
| 5477 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 0.22 |
| 5478 | DTI autoptx FA ilf l tract | GCST90385126 | 0.22 |
| 5479 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90132630 | 0.22 |
| 5480 | Low density lipoprotein cholesterol levels | GCST90278638 | 0.22 |
| 5481 | CRTAC1 levels | GCST90468870 | 0.22 |
| 5482 | Bread type - White | Diet | UKBB00000106 | 0.22 |
| 5483 | F7/VASN ratio | GCST90314745 | 0.22 |
| 5484 | Anti-human herpes virus 6 IE1A IgG seropositivity | GCST90006903 | 0.22 |
| 5485 | DTI autoptx MD slf r tract | GCST90385242 | 0.22 |
| 5486 | CD2AP levels | GCST90468617 | 0.22 |
| 5487 | Volume of left cortical nucleus | GCST90474964 | 0.22 |
| 5488 | C1QTNF9 levels | GCST90468491 | 0.22 |
| 5489 | ENDOU levels | GCST90469107 | 0.22 |
| 5490 | CRKL/PLA2G4A ratio | GCST90314271 | 0.22 |
| 5491 | BMP10 levels | GCST90468452 | 0.22 |
| 5492 | X-12095--N1-methyl-3-pyridone-4-carboxamide levels | GCST90243701 | 0.22 |
| 5493 | IDP T1 FAST ROIs L cerebellum X | GCST90002587 | 0.22 |
| 5494 | Number of correct matches in round | Pairs matching | UKBB00000532 | 0.22 |
| 5495 | TOMM20 levels | GCST90470931 | 0.22 |
| 5496 | Weight (UKB data field 21002) | GCST90468183 | 0.22 |
| 5497 | Diffuse idiopathic skeletal hyperostosis flow score | GCST90134532 | 0.22 |
| 5498 | HNRNPAB levels | GCST90088693 | 0.22 |
| 5499 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T232 | ECGU000232 | 0.22 |
| 5500 | IDP dMRI ProbtrackX ISOVF cgc r | GCST90004530 | 0.22 |
| 5501 | Disorders of lacrimal system | FING00000441 | 0.22 |
| 5502 | PRTN3 levels | GCST90470348 | 0.22 |
| 5503 | BCR/CLIP2 ratio | GCST90313486 | 0.22 |
| 5504 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475 | ECGA000475 | 0.22 |
| 5505 | Diabetes / Sugar | GCST90475265 | 0.22 |
| 5506 | ICD10 O14: Pre-eclampsia | GCST90454233 | 0.22 |
| 5507 | Hearing difficulty/problems with background noise | Hearing | UKBB00000312 | 0.21 |
| 5508 | Left-hemisphere control network to accumbens white-matter structural connectivity | GCST90302758 | 0.21 |
| 5509 | Nontoxic diffuse goitre | FING00000886 | 0.21 |
| 5510 | Witnessed sudden violent death | Traumatic events | UKBB00000917 | 0.21 |
| 5511 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51 | ECGA000051 | 0.21 |
| 5512 | FLT3/FLT3LG ratio | GCST90314859 | 0.21 |
| 5513 | GP2/LGALS8 ratio | GCST90314961 | 0.21 |
| 5514 | LGALS3 levels | GCST90179303 | 0.21 |
| 5515 | DNAJB14 levels | GCST90469011 | 0.21 |
| 5516 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79 | ECGU000079 | 0.21 |
| 5517 | Skin colour | Sun exposure | UKBB00000773 | 0.21 |
| 5518 | high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed) | GCST90475348 | 0.21 |
| 5519 | Acute pulmonary heart disease (PheCode 415.1) | GCST90475944 | 0.21 |
| 5520 | DTI autoptx MD atr l tract | GCST90385222 | 0.21 |
| 5521 | aseg rh intensity Thalamus-Proper | GCST90003782 | 0.21 |
| 5522 | Phosphate levels | GCST90200393 | 0.21 |
| 5523 | Left ventricular end-systolic volume | GCST90268126 | 0.21 |
| 5524 | ABHD14B/SCRN1 ratio | GCST90313145 | 0.21 |
| 5525 | PDIA4 levels | GCST90470195 | 0.21 |
| 5526 | Usual walking pace | Physical activity | UKBB00000891 | 0.21 |
| 5527 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 0.21 |
| 5528 | DLL1 levels | GCST90469004 | 0.21 |
| 5529 | Weight (mean, inv-normal transformed) | GCST90476463 | 0.21 |
| 5530 | Chronic ulcer of skin (PheCode 707) | GCST90476216 | 0.21 |
| 5531 | Total bilirubin levels | GCST90278643 | 0.21 |
| 5532 | FURIN/IGSF3 ratio | GCST90314885 | 0.21 |
| 5533 | aparc-a2009s rh volume G+S-subcentral | GCST90003002 | 0.21 |
| 5534 | Pain type(s) experienced in last month - None of the above | Pain | UKBB00000631 | 0.21 |
| 5535 | ACVRL1/EFNA4 ratio | GCST90313156 | 0.21 |
| 5536 | YWHAQ levels | GCST90471092 | 0.21 |
| 5537 | DKK1/LGALS8 ratio | GCST90314472 | 0.21 |
| 5538 | 1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels | GCST90200330 | 0.21 |
| 5539 | LYN/TACC3 ratio | GCST90315350 | 0.21 |
| 5540 | C2/SSC5D ratio | GCST90313555 | 0.21 |
| 5541 | ANGPTL1 levels | GCST90468302 | 0.21 |
| 5542 | EIF4G1/HEXIM1 ratio | GCST90314635 | 0.21 |
| 5543 | GSTA3/KRT18 ratio | GCST90314997 | 0.21 |
| 5544 | EREG/ITGB1BP2 ratio | GCST90314703 | 0.20 |
| 5545 | PPP1R14D levels | GCST90470303 | 0.20 |
| 5546 | NECTIN4/TGFBR2 ratio | GCST90315535 | 0.20 |
| 5547 | PLA2G10 levels | GCST90470244 | 0.20 |
| 5548 | CSTB levels | GCST90468898 | 0.20 |
| 5549 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428 | ECGU000428 | 0.20 |
| 5550 | Volume of left paralaminar nucleus | GCST90474985 | 0.20 |
| 5551 | TRIM40 levels | GCST90470968 | 0.20 |
| 5552 | Bread type: White (UKB data field 1448_1) | GCST90132964 | 0.20 |
| 5553 | 1-arachidonoylglycerophosphoethanolamine levels | GCST90243808 | 0.20 |
| 5554 | Duration of walks | Physical activity | UKBB00000200 | 0.20 |
| 5555 | Treatment or medication use - amlodipine (UKB data field 20003_1140879802) | GCST90042195 | 0.20 |
| 5556 | CXCL12 levels | GCST90468925 | 0.20 |
| 5557 | PTPN1/SCAMP3 ratio | GCST90315743 | 0.20 |
| 5558 | aparc-DKTatlas rh area parsopercularis | GCST90003281 | 0.20 |
| 5559 | Venous thromboembolism | GCST90399744 | 0.20 |
| 5560 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462 | ECGA000462 | 0.20 |
| 5561 | Nerve, nerve root and plexus disorders | FING00000862 | 0.20 |
| 5562 | Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivity | GCST90302764 | 0.20 |
| 5563 | Total protein levels | UKBB00000826 | 0.20 |
| 5564 | CRHBP/TREM2 ratio | GCST90314260 | 0.20 |
| 5565 | CCL18/TFPI ratio | GCST90313691 | 0.20 |
| 5566 | Bleeding | FING00000219 | 0.20 |
| 5567 | FCRL2 levels | GCST90469206 | 0.20 |
| 5568 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 0.20 |
| 5569 | BAP18 levels | GCST90468422 | 0.20 |
| 5570 | AHCY levels | GCST90468259 | 0.20 |
| 5571 | F-salty food liking (derived food-liking factor) | GCST90094827 | 0.20 |
| 5572 | Operation code - anterior/posterior repair bladder/uterus | Operations | UKBB00000548 | 0.20 |
| 5573 | Dissection of aorta | FING00000467 | 0.20 |
| 5574 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33 | ECGA000033 | 0.20 |
| 5575 | CD48 levels | GCST90425676 | 0.20 |
| 5576 | Triacylglycerol (52:4) [NL-16:0] levels | GCST90025170 | 0.20 |
| 5577 | T1 FreeSurfer a2009s rh G cuneus volume | GCST90385048 | 0.20 |
| 5578 | Major depressive disorder (ICD-10 coded) | GCST005903 | 0.20 |
| 5579 | DTI autoptx L3 slf l tract | GCST90385214 | 0.20 |
| 5580 | PSG1 levels | GCST90470353 | 0.20 |
| 5581 | DTI autoptx L2 slf r tract | GCST90385188 | 0.20 |
| 5582 | Ever had period extreme irritability | Mania | UKBB00000217 | 0.20 |
| 5583 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 0.20 |
| 5584 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243 | ECGU000243 | 0.20 |
| 5585 | Vitamin D | Blood biochemistry | UKBB00000902 | 0.20 |
| 5586 | CLEC1B/EGF ratio | GCST90314089 | 0.20 |
| 5587 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 0.20 |
| 5588 | CLEC1B/LGALS8 ratio | GCST90314096 | 0.20 |
| 5589 | OPHN1 levels | GCST90470126 | 0.20 |
| 5590 | Glucose (fasting status unknown, mean, inv-norm transformed) | GCST90475332 | 0.20 |
| 5591 | Ankylosing spondylitis, strict definition | FING00000090 | 0.19 |
| 5592 | Ceramide (d17:1/22:0) levels | GCST90024032 | 0.19 |
| 5593 | STIP1/TMSB10 ratio | GCST90315890 | 0.19 |
| 5594 | CEP43/PLXNB3 ratio | GCST90314020 | 0.19 |
| 5595 | SERPINB8 levels | GCST90470592 | 0.19 |
| 5596 | PITHD1 levels | GCST90470239 | 0.19 |
| 5597 | TBCB/TBCC ratio | GCST90315909 | 0.19 |
| 5598 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467 | ECGU000467 | 0.19 |
| 5599 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21 | ECGA000021 | 0.19 |
| 5600 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103 | ECGU000103 | 0.19 |
| 5601 | C4 levels | GCST90281042 | 0.19 |
| 5602 | DTI TBSS MD Fornix cres+Stria terminalis R | GCST90384610 | 0.19 |
| 5603 | MGLL/MITD1 ratio | GCST90315436 | 0.19 |
| 5604 | CD20 on IgD- CD27- B cell | GCST90001754 | 0.19 |
| 5605 | METAP1D/VASH1 ratio | GCST90315429 | 0.19 |
| 5606 | aparc-DKTatlas lh area superiorparietal | GCST90003261 | 0.19 |
| 5607 | THBD levels | GCST90470853 | 0.19 |
| 5608 | Plasma methylsuccinate levels in chronic kidney disease | GCST90265506 | 0.19 |
| 5609 | CERT/PRTFDC1 ratio | GCST90314029 | 0.19 |
| 5610 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476355 | 0.19 |
| 5611 | PDLIM5 levels | GCST90470197 | 0.19 |
| 5612 | TTR levels | GCST90470985 | 0.19 |
| 5613 | Omega-3 fatty acid levels | GCST90502441 | 0.19 |
| 5614 | CDKN2D levels | GCST90468685 | 0.19 |
| 5615 | ALB levels | GCST90018725 | 0.19 |
| 5616 | aparc-Desikan lh area postcentral | GCST90003094 | 0.19 |
| 5617 | CTRC levels | GCST90468906 | 0.19 |
| 5618 | EGLN1/LSP1 ratio | GCST90314617 | 0.19 |
| 5619 | IDP dMRI TBSS OD Genu of corpus callosum | GCST90004404 | 0.19 |
| 5620 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 0.19 |
| 5621 | DTI TBSS L3 Superior longitudinal fasciculus R | GCST90384564 | 0.19 |
| 5622 | FBP1/GSTA1 ratio | GCST90314786 | 0.19 |
| 5623 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502648 | 0.19 |
| 5624 | IDP dMRI ProbtrackX ICVF fma | GCST90004385 | 0.19 |
| 5625 | IGF1R levels | GCST90469524 | 0.19 |
| 5626 | LBR levels | GCST90469744 | 0.19 |
| 5627 | GBP2 levels | GCST90469312 | 0.19 |
| 5628 | Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels | GCST90060311 | 0.19 |
| 5629 | EPHB4/ESAM ratio | GCST90314679 | 0.19 |
| 5630 | GPC5 levels | GCST90469387 | 0.19 |
| 5631 | Phospholipid levels in large HDL | GCST90092852 | 0.19 |
| 5632 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242 | ECGU000242 | 0.19 |
| 5633 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475352 | 0.19 |
| 5634 | aparc-a2009s lh area G-postcentral | GCST90003324 | 0.19 |
| 5635 | Octadecenedioate (C18:1-DC) levels | GCST90200165 | 0.19 |
| 5636 | CMC1 levels | GCST90468794 | 0.19 |
| 5637 | Pancreas volume | GCST90016669 | 0.18 |
| 5638 | OTUD6B levels | GCST90470136 | 0.18 |
| 5639 | Hypopotassemia (PheCode 276.14) | GCST90475755 | 0.18 |
| 5640 | Neutrophill count | Blood count | UKBB00000497 | 0.18 |
| 5641 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486 | ECGA000486 | 0.18 |
| 5642 | Cholesteryl esters in HDL (UKB data field 23418) | GCST90269515 | 0.18 |
| 5643 | LRRC59 levels | GCST90469804 | 0.18 |
| 5644 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469 | ECGU000469 | 0.18 |
| 5645 | CD46/NID1 ratio | GCST90313833 | 0.18 |
| 5646 | ADA2/VCAM1 ratio | GCST90313167 | 0.18 |
| 5647 | Secondary thrombocytopenia (PheCode 287.32) | GCST90475810 | 0.18 |
| 5648 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497 | ECGU000497 | 0.18 |
| 5649 | Job involves heavy manual or physical work | Employment | UKBB00000383 | 0.18 |
| 5650 | Total lipids in large HDL (UKB data field 23559) | GCST90269656 | 0.18 |
| 5651 | NFX1 levels | GCST90470041 | 0.18 |
| 5652 | MED18/SH2B3 ratio | GCST90315412 | 0.18 |
| 5653 | Estimated glomerular filtration rate, serum creatinine | Other measurement | UKBB00000212 | 0.18 |
| 5654 | Glomerular filtration rate in non diabetics (creatinine) | GCST003401 | 0.18 |
| 5655 | Treatment speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000834 | 0.18 |
| 5656 | T1 FreeSurfer DK lh precentral thickness | GCST90385645 | 0.18 |
| 5657 | eGFR in diabetes mellitus (strict) case-control group (minimal adjustment) | GCST90624781 | 0.18 |
| 5658 | IL17A levels | GCST90469558 | 0.18 |
| 5659 | INSR levels | GCST90241509 | 0.18 |
| 5660 | AZU1 levels | GCST90468408 | 0.18 |
| 5661 | CDHR2 levels | GCST90468679 | 0.18 |
| 5662 | aparc-DKTatlas rh area precentral | GCST90003287 | 0.18 |
| 5663 | Urine N-acetylglutamate levels in chronic kidney disease | GCST90265569 | 0.18 |
| 5664 | ERBIN/SNAP29 ratio | GCST90314697 | 0.18 |
| 5665 | ACRBP levels | GCST90468205 | 0.18 |
| 5666 | Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels | GCST90060307 | 0.18 |
| 5667 | Triacylglycerol_53:3_[M+NH4]1+ levels | GCST90060528 | 0.18 |
| 5668 | GP2/SELE ratio | GCST90314962 | 0.18 |
| 5669 | CD40LG/TRAF2 ratio | GCST90313828 | 0.18 |
| 5670 | Hypertensive heart and/or renal disease (PheCode 401.2) | GCST90475924 | 0.18 |
| 5671 | Smoked fish liking | GCST90094841 | 0.18 |
| 5672 | DTI autoptx MD cgc r tract | GCST90385225 | 0.18 |
| 5673 | PARK7/TNFRSF9 ratio | GCST90315599 | 0.18 |
| 5674 | BA-exvivo rh area BA1 | GCST90003221 | 0.18 |
| 5675 | AMY2A levels | GCST90468298 | 0.18 |
| 5676 | aparc-pial rh area parstriangularis | GCST90003193 | 0.18 |
| 5677 | Treatment/medication code - ibuprofen | Medications | UKBB00000847 | 0.18 |
| 5678 | FGR/LBR ratio | GCST90314814 | 0.18 |
| 5679 | ANGPT1/CCN2 ratio | GCST90313261 | 0.18 |
| 5680 | Ulcerative colitis | GCST90018713 | 0.18 |
| 5681 | IDP dMRI ProbtrackX L1 ifo r | GCST90004259 | 0.18 |
| 5682 | CTSE levels | GCST90468911 | 0.18 |
| 5683 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481 | ECGA000481 | 0.18 |
| 5684 | DAG1/PDGFA ratio | GCST90314378 | 0.18 |
| 5685 | Hereditary ataxia | FING00000610 | 0.18 |
| 5686 | COL1A1/SOST ratio | GCST90314172 | 0.18 |
| 5687 | DARS1/EIF4B ratio | GCST90314403 | 0.18 |
| 5688 | Gout (PheCode 274.1) | GCST90475735 | 0.18 |
| 5689 | Current tobacco smoking | Smoking | UKBB00000161 | 0.18 |
| 5690 | ERN1 levels | GCST90469148 | 0.18 |
| 5691 | HYOU1/ROR1 ratio | GCST90315104 | 0.18 |
| 5692 | DAG1/GP6 ratio | GCST90314375 | 0.18 |
| 5693 | STAMBP levels | GCST90470756 | 0.17 |
| 5694 | Lysophosphatidylethanolamine-P_20:0_[M-H]1- levels | GCST90060147 | 0.17 |
| 5695 | Triacylglycerol_53:5_[M+NH4]1+ levels | GCST90060520 | 0.17 |
| 5696 | SELPLG levels | GCST90012046 | 0.17 |
| 5697 | CERT levels | GCST90468717 | 0.17 |
| 5698 | ERP29 levels | GCST90469149 | 0.17 |
| 5699 | CD200/CNTNAP2 ratio | GCST90313747 | 0.17 |
| 5700 | Psoriatic arthropathies | FING00001225 | 0.17 |
| 5701 | CD38 levels | GCST90468628 | 0.17 |
| 5702 | MDH1 levels | GCST90469876 | 0.17 |
| 5703 | Major dietary changes in the last 5 years - Yes, because of illness | Diet | UKBB00000422 | 0.17 |
| 5704 | Propionylcarnitine levels | GCST90243593 | 0.17 |
| 5705 | Triglyceride to phosphoglyceride ratio | GCST90454483 | 0.17 |
| 5706 | Administrative and legal statuses - NHS patient: not formally detained | Summary Administration | UKBB00000012 | 0.17 |
| 5707 | eGFR in diabetes mellitus (full adjustment) | GCST90624786 | 0.17 |
| 5708 | PCSK9 levels | GCST90428110 | 0.17 |
| 5709 | Free cholesterol in large HDL (UKB data field 23563) | GCST90269660 | 0.17 |
| 5710 | GFRA3 levels | GCST90469330 | 0.17 |
| 5711 | Fasting blood glucose | GCST000568 | 0.17 |
| 5712 | DCTD levels | GCST90468957 | 0.17 |
| 5713 | BMPER levels | GCST90468455 | 0.17 |
| 5714 | GFRA2 levels | GCST90469329 | 0.17 |
| 5715 | Fracture of upper limb (PheCode 803) | GCST90476279 | 0.17 |
| 5716 | CLSTN2 levels | GCST90468789 | 0.17 |
| 5717 | ALCAM/NOTCH1 ratio | GCST90313241 | 0.17 |
| 5718 | MCAM/NTRK3 ratio | GCST90315409 | 0.17 |
| 5719 | Retinal nerve fibre layer (RNFL) thickness | GCST90014266 | 0.17 |
| 5720 | Smoking status - Current | Smoking | UKBB00000779 | 0.17 |
| 5721 | Risk taking (standard GWA) | GCST90267298 | 0.17 |
| 5722 | CRADD levels | GCST90468854 | 0.17 |
| 5723 | Adhesive capsulitis of shoulder | FING00000043 | 0.17 |
| 5724 | Degree of unsaturation | GCST90502736 | 0.17 |
| 5725 | IDP T1 SIENAX brain-unnormalised volume | GCST90002435 | 0.17 |
| 5726 | CD200R1/CLEC4G ratio | GCST90313748 | 0.17 |
| 5727 | GART levels | GCST90469303 | 0.17 |
| 5728 | CCL14 levels | GCST90468566 | 0.17 |
| 5729 | aparc-a2009s rh volume G-postcentral | GCST90003026 | 0.17 |
| 5730 | CXCL16 levels | GCST90012059 | 0.17 |
| 5731 | CASP8 levels | GCST90468548 | 0.17 |
| 5732 | DTI TBSS L1 Posterior limb of internal capsule R | GCST90384446 | 0.17 |
| 5733 | RAP1A levels | GCST90470425 | 0.17 |
| 5734 | MET/PTPRF ratio | GCST90315435 | 0.17 |
| 5735 | creatinine (mean, inv-norm transformed) | GCST90475229 | 0.16 |
| 5736 | MAVS/SCAMP3 ratio | GCST90315396 | 0.16 |
| 5737 | MANF levels | GCST90469846 | 0.16 |
| 5738 | Herring liking | GCST90094781 | 0.16 |
| 5739 | Substance dependence | GCST90018704 | 0.16 |
| 5740 | FGFR2 levels | GCST90469233 | 0.16 |
| 5741 | red blood cell count (RBC, minimum, inv-norm transformed) | GCST90476353 | 0.16 |
| 5742 | VPS37A levels | GCST90471046 | 0.16 |
| 5743 | Hip circumference | GCST90278633 | 0.16 |
| 5744 | ITGB1/MCAM ratio | GCST90315226 | 0.16 |
| 5745 | RNASE3 levels | GCST90470477 | 0.16 |
| 5746 | CASP3/PDGFB ratio | GCST90313638 | 0.16 |
| 5747 | HTRA2 levels | GCST90469494 | 0.16 |
| 5748 | CRELD2/ERP44 ratio | GCST90314253 | 0.16 |
| 5749 | Belittlement by partner or ex-partner as an adult | Traumatic events | UKBB00000091 | 0.16 |
| 5750 | SLC35G2 levels | GCST90242857 | 0.16 |
| 5751 | ESAM/TNFRSF14 ratio | GCST90314720 | 0.16 |
| 5752 | Total cholesterol levels | GCST90278644 | 0.16 |
| 5753 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81 | ECGA000081 | 0.16 |
| 5754 | DTI TBSS L3 Retrolenticular part of internal capsule R | GCST90384544 | 0.16 |
| 5755 | Cardiovascular disease | GCST90086057 | 0.16 |
| 5756 | HDLBP levels | GCST90087533 | 0.16 |
| 5757 | DOK2/SNX9 ratio | GCST90314539 | 0.16 |
| 5758 | QDPR levels | GCST90470400 | 0.16 |
| 5759 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427 | ECGU000427 | 0.16 |
| 5760 | AHSA1 levels | GCST90468262 | 0.16 |
| 5761 | CTSD/PRCP ratio | GCST90314312 | 0.16 |
| 5762 | AXIN1/HEXIM1 ratio | GCST90313408 | 0.16 |
| 5763 | PPP1R12A/SPARC ratio | GCST90315712 | 0.16 |
| 5764 | TCN1 levels | GCST90470819 | 0.16 |
| 5765 | SSC4D levels | GCST90470747 | 0.16 |
| 5766 | FUCA1 levels | GCST90469275 | 0.16 |
| 5767 | Enteritis due to Yersinia enterocolitica | FING00000505 | 0.16 |
| 5768 | MTHFSD levels | GCST90469956 | 0.16 |
| 5769 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491 | ECGU000491 | 0.16 |
| 5770 | PROS1 levels | GCST90470337 | 0.16 |
| 5771 | Other diseases of the respiratory system | FING00001011 | 0.16 |
| 5772 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42 | ECGA000042 | 0.16 |
| 5773 | CLEC1B/VTA1 ratio | GCST90314107 | 0.16 |
| 5774 | Coronary heart disease | GCST000998 | 0.16 |
| 5775 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20 | ECGA000020 | 0.16 |
| 5776 | aparc-DKTatlas lh area precentral | GCST90003256 | 0.16 |
| 5777 | S100A14 levels | GCST90470515 | 0.16 |
| 5778 | Left ventricular end diastolic mass | GCST90268123 | 0.16 |
| 5779 | AXL levels | GCST90468406 | 0.16 |
| 5780 | Free cholesterol to total lipids in small HDL percentage (UKB data field 23647) | GCST90269744 | 0.16 |
| 5781 | T1 FreeSurfer DKT lh precentral thickness | GCST90384246 | 0.16 |
| 5782 | Urolithiasis | GCST90018715 | 0.16 |
| 5783 | CD27/CD79B ratio | GCST90313770 | 0.16 |
| 5784 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 0.16 |
| 5785 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484 | ECGU000484 | 0.16 |
| 5786 | RTBDN levels | GCST90470505 | 0.16 |
| 5787 | Occupational creativity | GCST90308774 | 0.16 |
| 5788 | aseg rh volume CerebralWhiteMatter | GCST90002632 | 0.16 |
| 5789 | Vanillylmandelate (VMA) levels | GCST90200309 | 0.16 |
| 5790 | DTI autoptx L1 ifo r tract | GCST90385152 | 0.16 |
| 5791 | DTI autoptx L2 atr l tract | GCST90385168 | 0.16 |
| 5792 | GNLY/GZMA ratio | GCST90314949 | 0.16 |
| 5793 | TRIM58 levels | GCST90470969 | 0.16 |
| 5794 | BSG/LAMP3 ratio | GCST90313533 | 0.16 |
| 5795 | ICD10 O24.4: Diabetes mellitus arising in pregnancy | GCST90454236 | 0.16 |
| 5796 | CDHR5 levels | GCST90468680 | 0.16 |
| 5797 | CDH6 levels | GCST90468677 | 0.16 |
| 5798 | Flavonifractor sp002159265 abundance in stool | GCST90032400 | 0.16 |
| 5799 | DTI TBSS L2 Cingulum hippocampus L | GCST90384513 | 0.16 |
| 5800 | Word interpolation | Fluid intelligence / reasoning | UKBB00000918 | 0.16 |
| 5801 | IL19 levels | GCST90469568 | 0.16 |
| 5802 | AXIN1/MAP2K6 ratio | GCST90313413 | 0.16 |
| 5803 | CPXM1/MDK ratio | GCST90314221 | 0.16 |
| 5804 | CSF1/SEMA3F ratio | GCST90314288 | 0.16 |
| 5805 | Tooth agenesis EXCLUDE clefts and syndromes | FING00001368 | 0.16 |
| 5806 | LGMN/TIMP1 ratio | GCST90315325 | 0.15 |
| 5807 | Atopic dermatitis | GCST90027161 | 0.15 |
| 5808 | Fasting glucose | GCST90002232 | 0.15 |
| 5809 | TFF3 levels | GCST90470837 | 0.15 |
| 5810 | PDLIM7/TBC1D23 ratio | GCST90315640 | 0.15 |
| 5811 | NRGN levels | GCST90470083 | 0.15 |
| 5812 | CD69/CDKN2D ratio | GCST90313866 | 0.15 |
| 5813 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12 | ECGA000012 | 0.15 |
| 5814 | LRCH4 levels | GCST90469791 | 0.15 |
| 5815 | CDH2/SSC4D ratio | GCST90313951 | 0.15 |
| 5816 | CRADD/EREG ratio | GCST90314236 | 0.15 |
| 5817 | IDP dMRI ProbtrackX MD ptr r | GCST90004239 | 0.15 |
| 5818 | HEG1 levels | GCST90469444 | 0.15 |
| 5819 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470 | ECGA000470 | 0.15 |
| 5820 | Neutrophill count (UKB data field 30140) | GCST90468092 | 0.15 |
| 5821 | CKMB levels | GCST90475221 | 0.15 |
| 5822 | TREML2 levels | GCST90470962 | 0.15 |
| 5823 | EGF/GP6 ratio | GCST90314608 | 0.15 |
| 5824 | 2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels | GCST90200233 | 0.15 |
| 5825 | IDP dMRI ProbtrackX L1 str l | GCST90004269 | 0.15 |
| 5826 | APOA1 levels | GCST90269537 | 0.15 |
| 5827 | GSTA1/KRT18 ratio | GCST90314993 | 0.15 |
| 5828 | DTI autoptx L2 ilf r tract | GCST90385181 | 0.15 |
| 5829 | MAP3K5/MAVS ratio | GCST90315379 | 0.15 |
| 5830 | SEPTIN3 levels | GCST90470576 | 0.15 |
| 5831 | Falls in the last year | General health | UKBB00000235 | 0.15 |
| 5832 | IDP T1 SIENAX brain-normalised volume | GCST90002434 | 0.15 |
| 5833 | CCN1 levels | GCST90468587 | 0.15 |
| 5834 | Operative procedures - Direct current cardioversion | Summary Operations | UKBB00000576 | 0.15 |
| 5835 | ANGPT1/CPXM1 ratio | GCST90313262 | 0.15 |
| 5836 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | GCST90004362 | 0.15 |
| 5837 | IDP dMRI TBSS L1 Posterior corona radiata L | GCST90004102 | 0.15 |
| 5838 | Pre-eclampsia or poor fetal growth | FING00001202 | 0.15 |
| 5839 | IDP T1 FAST ROIs L cerebellum I-IV | GCST90002562 | 0.15 |
| 5840 | Other disorders of the musculoskeletal system and connective tissue | FING00001038 | 0.15 |
| 5841 | SMAD2 levels | GCST90470676 | 0.15 |
| 5842 | aparc-a2009s rh area G-precentral | GCST90003399 | 0.15 |
| 5843 | Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary Administration | UKBB00000466 | 0.15 |
| 5844 | T1 CAT volume R SupramarginalGyrusanteriordivision | GCST90384037 | 0.15 |
| 5845 | IDP dMRI TBSS MD Cerebral peduncle L | GCST90004042 | 0.15 |
| 5846 | PTRHD1 levels | GCST90470389 | 0.15 |
| 5847 | Rosacea (PheCode 695.3) | GCST90476178 | 0.15 |
| 5848 | What is your weight? (pounds, inv-normal transformed) | GCST90476469 | 0.15 |
| 5849 | APP/CD40LG ratio | GCST90313319 | 0.15 |
| 5850 | T1 FreeSurfer DKT rh insula area | GCST90384317 | 0.15 |
| 5851 | Principal component-derived dietary pattern 42 | GCST90133047 | 0.15 |
| 5852 | Systolic blood pressure | GCST90278642 | 0.15 |
| 5853 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 0.15 |
| 5854 | LRPAP1 levels | GCST90469800 | 0.15 |
| 5855 | Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | GCST90475091 | 0.15 |
| 5856 | Chronic ulcer of leg or foot (PheCode 707.2) | GCST90476218 | 0.15 |
| 5857 | EDAR/EGF ratio | GCST90314573 | 0.15 |
| 5858 | NTF3 levels | GCST90470094 | 0.15 |
| 5859 | DGKA levels | GCST90468989 | 0.15 |
| 5860 | HippSubfield lh volume Whole-hippocampal-body | GCST90002687 | 0.15 |
| 5861 | PTS levels | GCST90470390 | 0.15 |
| 5862 | aparc-a2009s rh volume S-oc-middle+Lunatus | GCST90003055 | 0.15 |
| 5863 | HS6ST1 levels | GCST90469479 | 0.15 |
| 5864 | DTI TBSS MD Anterior corona radiata R | GCST90384594 | 0.15 |
| 5865 | DTI TBSS MD Sagittal stratum R | GCST90384602 | 0.15 |
| 5866 | REST UKBBICA NODEamps25 0007 | GCST90385490 | 0.15 |
| 5867 | DTI autoptx L3 unc r tract | GCST90385219 | 0.15 |
| 5868 | FAM20A levels | GCST90469185 | 0.15 |
| 5869 | Coffee type - Instant coffee | Diet | UKBB00000141 | 0.15 |
| 5870 | Physical decline (log-difference score) | GCST90565847 | 0.15 |
| 5871 | CD40/CRELD2 ratio | GCST90313811 | 0.15 |
| 5872 | Principal component-derived dietary pattern 2 | GCST90133007 | 0.15 |
| 5873 | F7/F9 ratio | GCST90314743 | 0.15 |
| 5874 | PTPRB levels | GCST90470379 | 0.15 |
| 5875 | PLSCR3 levels | GCST90470261 | 0.15 |
| 5876 | FCER2/TREML2 ratio | GCST90314792 | 0.15 |
| 5877 | EFCAB14 levels | GCST90469076 | 0.15 |
| 5878 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis L | GCST90004366 | 0.15 |
| 5879 | LAYN levels | GCST90469742 | 0.15 |
| 5880 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480 | ECGU000480 | 0.14 |
| 5881 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | GCST90475094 | 0.14 |
| 5882 | PPP1R14A levels | GCST90470302 | 0.14 |
| 5883 | ESAM/PDGFB ratio | GCST90314714 | 0.14 |
| 5884 | PLA2G4A/SNX9 ratio | GCST90315670 | 0.14 |
| 5885 | GZMA/TNFRSF4 ratio | GCST90315013 | 0.14 |
| 5886 | Concentration of large HDL particles (UKB data field 23558) | GCST90269655 | 0.14 |
| 5887 | CD69 levels | GCST90468643 | 0.14 |
| 5888 | aseg lh volume CerebralWhiteMatter | GCST90002615 | 0.14 |
| 5889 | Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4) | GCST90475984 | 0.14 |
| 5890 | PLPBP levels | GCST90470260 | 0.14 |
| 5891 | FLT1/TFPI2 ratio | GCST90314856 | 0.14 |
| 5892 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 0.14 |
| 5893 | GMPR2 levels | GCST90469367 | 0.14 |
| 5894 | Keloid | GCST90018654 | 0.14 |
| 5895 | KRT18 levels | GCST90469716 | 0.14 |
| 5896 | CD20 on IgD- CD38- B cell | GCST90001755 | 0.14 |
| 5897 | ABO levels | GCST90468191 | 0.14 |
| 5898 | CLEC1B/MPIG6B ratio | GCST90314098 | 0.14 |
| 5899 | Fresh fruit intake | Diet | UKBB00000272 | 0.14 |
| 5900 | ROR1/THBD ratio | GCST90315786 | 0.14 |
| 5901 | PLCB2 levels | GCST90470255 | 0.14 |
| 5902 | FKBP5/MITD1 ratio | GCST90314844 | 0.14 |
| 5903 | HDL cholesterol levels | GCST90092822 | 0.14 |
| 5904 | TAFA5 levels | GCST90470800 | 0.14 |
| 5905 | MAN1A2 levels | GCST90469843 | 0.14 |
| 5906 | MYOM2 levels | GCST90469985 | 0.14 |
| 5907 | HBEGF levels | GCST90241392 | 0.14 |
| 5908 | ADM levels | GCST90468246 | 0.14 |
| 5909 | Duration of vigorous activity | Physical activity | UKBB00000199 | 0.14 |
| 5910 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39 | ECGA000039 | 0.14 |
| 5911 | SIRT2/STAT5B ratio | GCST90315846 | 0.14 |
| 5912 | SYTL4 levels | GCST90470795 | 0.14 |
| 5913 | COMT levels | GCST90468828 | 0.14 |
| 5914 | BCR/ICA1 ratio | GCST90313493 | 0.14 |
| 5915 | Eosinophil percentage of white cells variance | GCST90565690 | 0.14 |
| 5916 | Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000445 | 0.14 |
| 5917 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480 | ECGA000480 | 0.14 |
| 5918 | EBAG9/EDAR ratio | GCST90314563 | 0.14 |
| 5919 | S100A11/SERPINB8 ratio | GCST90315799 | 0.14 |
| 5920 | COMP/ITGAV ratio | GCST90314190 | 0.14 |
| 5921 | Insomnia complaints | GCST004695 | 0.14 |
| 5922 | FAM3B/GPA33 ratio | GCST90314778 | 0.14 |
| 5923 | VASN levels | GCST90471027 | 0.14 |
| 5924 | aparc-Desikan lh area parstriangularis | GCST90003092 | 0.14 |
| 5925 | aparc-a2009s rh volume G-parietal-sup | GCST90003025 | 0.14 |
| 5926 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 0.14 |
| 5927 | CMIP levels | GCST90468795 | 0.14 |
| 5928 | NT5C1A levels | GCST90470090 | 0.14 |
| 5929 | GNLY levels | GCST90469372 | 0.14 |
| 5930 | Pulmonary heart disease (PheCode 415) | GCST90475942 | 0.14 |
| 5931 | NELL1 levels | GCST90470026 | 0.14 |
| 5932 | UFD1 levels | GCST90471005 | 0.14 |
| 5933 | SCN4B levels | GCST90470551 | 0.14 |
| 5934 | FABP1/LGALS4 ratio | GCST90314752 | 0.14 |
| 5935 | Ptosis of eyelid | FING00001227 | 0.14 |
| 5936 | MGLL/STK4 ratio | GCST90315443 | 0.14 |
| 5937 | Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302677 | 0.13 |
| 5938 | aparc-Desikan lh volume superiorparietal | GCST90002796 | 0.13 |
| 5939 | KITLG/PLTP ratio | GCST90315252 | 0.13 |
| 5940 | CALB2 levels | GCST90468527 | 0.13 |
| 5941 | BCAN/MOG ratio | GCST90313480 | 0.13 |
| 5942 | Colon cancer (PheCode 153.2) | GCST90475567 | 0.13 |
| 5943 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98 | ECGU000098 | 0.13 |
| 5944 | Weight (maximum, inv-normal transformed) | GCST90476460 | 0.13 |
| 5945 | Dyslipidemia | GCST90086077 | 0.13 |
| 5946 | KLK6/MOG ratio | GCST90315255 | 0.13 |
| 5947 | IDP dMRI TBSS MD Posterior corona radiata L | GCST90004054 | 0.13 |
| 5948 | GRP levels | GCST90241242 | 0.13 |
| 5949 | RWDD1 levels | GCST90470510 | 0.13 |
| 5950 | Phosphatidate_34:2_[M-H]1- levels | GCST90060223 | 0.13 |
| 5951 | BLVRB/HBQ1 ratio | GCST90313525 | 0.13 |
| 5952 | IFNGR1 levels | GCST90469513 | 0.13 |
| 5953 | Pregnenediol disulfate (C21H34O8S2) levels | GCST90199840 | 0.13 |
| 5954 | LTA/LTBR ratio | GCST90315336 | 0.13 |
| 5955 | DTX3 levels | GCST90469048 | 0.13 |
| 5956 | Biliary cirrhosis, NAS | FING00000213 | 0.13 |
| 5957 | DLL1/TGFBR2 ratio | GCST90314499 | 0.13 |
| 5958 | RBKS levels | GCST90470433 | 0.13 |
| 5959 | DTI TBSS L3 Cingulum hippocampus R | GCST90384560 | 0.13 |
| 5960 | MGLL levels | GCST90469901 | 0.13 |
| 5961 | KLRK1 levels | GCST90469713 | 0.13 |
| 5962 | SHBG levels | GCST90503315 | 0.13 |
| 5963 | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels | GCST90200067 | 0.13 |
| 5964 | FABP4 levels | GCST90469176 | 0.13 |
| 5965 | Avoided activities or situations because of previous stressful experience in past month | Traumatic events | UKBB00000083 | 0.13 |
| 5966 | GALNT10/IGSF3 ratio | GCST90314914 | 0.13 |
| 5967 | T1 FreeSurfer BA rh V2 exvivo thickness | GCST90385571 | 0.13 |
| 5968 | IL16 levels | GCST90241596 | 0.13 |
| 5969 | FST levels | GCST90012080 | 0.13 |
| 5970 | LY6D levels | GCST90469821 | 0.13 |
| 5971 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479 | ECGA000479 | 0.13 |
| 5972 | Frailty index | GCST90020053 | 0.13 |
| 5973 | IDP T1 SIENAX grey unnormalised volume | GCST90002431 | 0.13 |
| 5974 | Noninfectious disorders of lymphatic channels (PheCode 450) | GCST90476002 | 0.13 |
| 5975 | EIF4B/MAP4K5 ratio | GCST90314623 | 0.13 |
| 5976 | FAS levels | GCST90090701 | 0.13 |
| 5977 | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | GCST90004345 | 0.13 |
| 5978 | IGSF8/NECTIN2 ratio | GCST90315140 | 0.13 |
| 5979 | Transient ischemic attack | FING00001375 | 0.13 |
| 5980 | aseg lh volume Pallidum | GCST90002623 | 0.13 |
| 5981 | wg rh intensity-contrast transversetemporal | GCST90003860 | 0.13 |
| 5982 | SSC4D/TNFSF10 ratio | GCST90315887 | 0.13 |
| 5983 | T1 FreeSurfer BA rh BA3b exvivo area | GCST90385550 | 0.13 |
| 5984 | Free cholesterol to total lipids ratio in very large HDL | GCST90093009 | 0.13 |
| 5985 | F2R/SEMA4D ratio | GCST90314734 | 0.13 |
| 5986 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496 | ECGU000496 | 0.13 |
| 5987 | Serum 25-Hydroxyvitamin D level variance | GCST90000621 | 0.13 |
| 5988 | AK1 levels | GCST90468269 | 0.13 |
| 5989 | CREG1/GUSB ratio | GCST90314249 | 0.13 |
| 5990 | Free cholesterol to total lipids ratio in medium HDL | GCST90092897 | 0.13 |
| 5991 | Asthma | GCST90018575 | 0.13 |
| 5992 | aparc-a2009s lh area G-parietal-sup | GCST90003323 | 0.13 |
| 5993 | DTI autoptx MD slf l tract | GCST90385241 | 0.13 |
| 5994 | TEK levels | GCST90012013 | 0.13 |
| 5995 | MCEMP1 levels | GCST90469872 | 0.13 |
| 5996 | GP6 levels | GCST90469384 | 0.13 |
| 5997 | IDP dMRI ProbtrackX L1 fmi | GCST90004257 | 0.13 |
| 5998 | aparc-pial lh area postcentral | GCST90003162 | 0.13 |
| 5999 | CPXM1/DKK1 ratio | GCST90314218 | 0.13 |
| 6000 | Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivity | GCST90302793 | 0.13 |